We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Urine Particle Analyzer Compared with Standard Methods

By LabMedica International staff writers
Posted on 20 Nov 2017
Print article
Image: The UF-1000i automated urine particle analyzer (Photo courtesy of Sysmex).
Image: The UF-1000i automated urine particle analyzer (Photo courtesy of Sysmex).
Urinary tract infections (UTIs) are characterized by the presence of microbial pathogens within the urinary tract, and they represent one of the most common infections identified in both hospitalized and clinic patients. Most UTIs are easily treated without difficulty.

In certain patient populations, such as children, pregnant women, and the elderly, significant complications may arise. The symptoms observed with UTIs are diverse and can range from mild irritation with voiding to bacteremia or even sepsis. When sepsis is present, it can lead to death if it is not diagnosed and treated early.

Medical scientists working at Prescient Medicine (Hummelstown, PA, USA) and their colleagues compared data from urine samples collected in sterile containers for bacterial culture and microscopic analysis during a 3-month period in a laboratory at a 572-bed, acute-care hospital. Upon receipt, one sample was used to inoculate a 5% sheep blood agar and a MacConkey agar plate with a 0.001-mL calibrated loop.

The second sample was analyzed for bacteria and leukocytes with the Sysmex UF-1000i urine analyzer (Sysmex Corporation, Kobe, Japan) which is a fully automated, fluorescent flow cytometer that categorizes red blood cells, white blood cells, epithelial cells, small round cells, sperm cells, crystals, and pathologic and hyaline casts, yeast, and bacteria. The second sample was also analyzed by urinalysis-associated microscopy for the presence of epithelial cells, leukocytes, yeast, and bacteria.

Urine cultures showed no growth in 2,034 samples (50%) and growth of less than 104 colony-forming units (CFUs)/mL in 1,812 samples (45%). Of the 4.033 results, 754 samples (19%) showed bacterial growth of 105 CFUs/mL or more, and 190 samples (5%) were considered contaminated specimens because they contained multiple species. However, if the growth of bacteria exceeded the definition of a negative result, they were considered to be positive, even though the likelihood of a UTI was low in those patients. Of the culture-positive samples, the most commonly identified microorganisms were Escherichia coli and Klebsiella spp, which is consistent with known epidemiologic data.

Of the 4,033 unique urine samples obtained from adult patients, 2,736 (67.8%) specimens had positive white blood cell counts and bacteria and 1,215 (30.1%) specimens had negative white blood cell counts and bacteria as reported by the UF-1000i. The negative predictive value for any positive culture in the adult population included in the study was 95.5%, and the negative predictive value for positive cultures containing growth of 100,000 or more CFUs was 99.3% using the Sysmex UF-1000i. There were 373 unique urine specimens collected in pediatric patients and using the UF-1000i method, 269 specimens (72%) had positive white blood cell counts and bacteria, and 104 (27.9%) tested negative for an elevation in white blood cell counts and bacteria.

The authors concluded that the Sysmex UF-1000i showed 98% sensitivity and 93.7% specificity with a 95.5% negative predictive value. Thus, a negative screen with the UF-1000i using defined thresholds for white blood cell counts and bacteria was likely to be a true negative, decreasing the need for presumptive antibiotics. The study was published in the November 2017 issue of the journal Archives of Pathology & Laboratory Medicine.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.